Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
US8288371B2 · kind B2 · utility
1Cited by
1References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2008 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Aug 15, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formulaare disclosed. The compounds are CCR1 antagonists which are useful for the treatment and prevention of inflammatory and autoimmune diseases. Other embodiments are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.